Back
CVS Health Quote, Financials, Valuation and Earnings
Sponsored
CVS
Sponsored
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
45
CVS
CVS Health
Last Price:
56.83
Seasonality Move:
6.34%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.CVS Health Price Quote
$56.83
+1.06 (+1.9%)
(Updated: November 20, 2024 at 5:55 PM ET)
CVS Health Key Stats
Sell
45
CVS Health (CVS)
is a Sell
Day range:
$55.28 - $56.71
52-week range:
$52.71 - $83.25
Dividend yield:
4.75%
P/E ratio:
8.66
P/S ratio:
0.19
P/B ratio:
0.94%
Volume:
11.4M
Avg. volume:
13.6M
1-year change:
-18.95%
Market cap:
$70.5B
Revenue:
$357.8B
EPS:
$3.94
How Much Does CVS Health Make?
-
How Much Are CVS Health's Sales Annually?
CVS Revenues are $357.8B -
How Much Profit Does CVS Health's Make A Year?
CVS net income is $8.3B
Is CVS Health Growing As A Company?
-
What Is CVS Health's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.06% -
What Is CVS Health's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.96%
CVS Health Stock Price Performance
-
Did CVS Health Stock Go Up Last Month?
CVS Health share price went down by -7.57% last month -
Did CVS's Share Price Rise Over The Last Year?
CVS share price fell by -18.95% over the past 1 year
What Is CVS Health 52-Week High & Low?
-
What Is CVS Health’s 52-Week High Share Price?
CVS Health has traded as high as $83.25 over the past 52 weeks -
What Is CVS Health’s 52-Week Low Share Price?
CVS Health has traded as low as $52.71 over the past 52 weeks
CVS Health Price To Free Cash Flow
-
Is CVS Health Stock Overvalued?
CVS Health is trading at a price to free cash flow ratio of 42.18 -
Is CVS Health Stock Undervalued?
CVS Health EV to Free Cash Flow ratio is 75.01 -
What Is CVS Health’s Price Earnings Growth Ratio?
CVS PEG ratio is 0.00 -
Is CVS Health Trading At A Premium To Earnings?
CVS Health EV to EBIT ratio is 13.16
Is It Risky To Buy CVS Health?
-
How Much Debt Does CVS Health Have?
Total long term debt quarterly is $65.5B -
How Much Cash Does CVS Health Have?
Cash and short term investments quarterly total is $9.7B -
What Is CVS Health’s Book Value Per Share?
Book value per share is 59.57
Is CVS Health Cash Flow Positive?
-
What Is CVS Cash Flow From Operations?
Cash flow from operations (TTM) is $4.6B -
What Is CVS Health’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$2.5B -
What Is CVS Health’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$8.3B
CVS Health Return On Invested Capital
-
Is Management Doing A Good Job?
CVS return on invested capital is 3.61% -
What Is CVS Health Return On Assets?
ROA measures how assets are converting to revenues and is 2% -
What Is CVS Return On Equity?
ROE is a measure of profitability and is 6.68%
CVS Health Earnings Date & Stock Price
-
What Is CVS Health's Stock Price Today?
A single share of CVS can be purchased today for 55.77 -
What Is CVS Health’s Stock Symbol?
CVS Health trades on the S&P500 under the ticker symbol: CVS -
When Is CVS Health’s Next Earnings Date?
The next quarterly earnings date for CVS Health is scheduled on February 7, 2025 -
When Is CVS's next ex-dividend date?
CVS Health's next ex-dividend date is October 21, 2024 -
How To Buy CVS Health Stock?
You can buy CVS Health shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
CVS Health Competitors
-
Who Are CVS Health's Competitors?
Below is a list of companies who compete with CVS Health or are related in some way:
CVS Health Dividend Yield
-
What Is CVS Dividend Yield?
CVS Health’s dividend yield currently is 4.75% -
What Is CVS Health’s Payout Ratio?
CVS Health’s payout ratio is 66.07% -
When Did CVS Health Last Pay A Dividend?
The latest dividend pay date is November 21, 2024 -
What Is CVS Health’s Dividend Per Share?
CVS Health pays a dividend of $0.67 per share
CVS Health Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | -96% | -26.09% |
Revenue: | 6.31% | 2.96% |
Analyst Recommendations
Buy Recommendations: | 11 |
---|---|
Hold Recommendations: | 11 |
Sell Recommendations: | 0 |
Price Target: | 68.94 |
Upside from Last Price: | 23.61% |